The IPO comprises a fresh issue of 45.84 lakh equity shares through the book-building route
Read MoreThis novel anti-infective, invented by Orchid Pharma, aims to address the rising threat of antimicrobial resistance (AMR) and has been approved for the treatment of complicated urinary tract infections (cUTI), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP)
Read MoreResearch by the American Medical Association (AMA) supports this digital transformation, finding that 9 in 10 physicians see benefits in digital health tools
Read MoreThis marks India’s second youngest case of a successful cochlear implant
Read MoreThis acquisition is expected to enhance HCG's annual EBITDA by Rs 3 per share
Read MoreIn an exclusive interaction with BW Healthcare World, Sandeep Verma, Country Head for India, Bangladesh, and Sri Lanka at Bayer Consumer Health Division, shared insights on how Bayer is uniquely positioned to address the rising interest in self-care and the company's strategic plans for the Indian market
Read MoreThe 'Swasth Mahila Swasth Bharat' project aims to screen 1,50,000 women for breast cancer over the next 12 months across 15 states, focusing on under-represented and under-resourced communities
Read MoreThe program will include comprehensive discussions, demonstrations, and hands-on training focusing on robotic and stereotactic radiosurgery.
Read MoreData suggests that 1.2 million deaths in India are due to antimicrobial resistance (AMR), with an estimated 10 million deaths by 2050
Read MorePorwal will lead portfolio management and collaborate closely with the founders and operating teams of 2070 Health to drive the growth and success of the studio’s portfolio companies
Read More